高风险内镜逆行胰胆管造影术中预防性胰腺支架置入获益相关的技术因素:SVI试验数据集的二次分析
该研究为SVI试验数据集的二次分析,纳入787例成功置入预防性胰腺支架的患者,评估5项可调整技术因素与内镜逆行胰胆管造影术后胰腺炎的关系。结果显示各技术因素与术后胰腺炎均无明确关联,预防性胰腺支架的获益对技术操作差异似乎稳健。
要点
- 787例成功置入预防性胰腺支架患者中91例发生术后胰腺炎。
- 为预防性支架专门行胰管导丝置入与自然发生相比,胰腺炎风险无明确关联(OR 0.82,95%CI 0.37-1.84)。
- 支架长度、直径、导丝口径及置入所费努力与术后胰腺炎均无明确关联。
核心结论
- 5项可调整技术因素对预防性胰腺支架预防高风险内镜逆行胰胆管造影术后胰腺炎的获益似乎没有强烈影响。
- 在事后亚组分析的局限内,这些发现可能对操作决策有重要意义,并提示预防性胰腺支架的获益对技术操作差异稳健。
研究设计与样本
- SVI试验数据集的二次分析,纳入787例成功置入预防性胰腺支架的临床试验患者。
- 采用逻辑回归模型检验各技术因素与内镜逆行胰胆管造影术后胰腺炎的校正关联。
主要发现
- 787例患者中91例发生内镜逆行胰胆管造影术后胰腺炎。
- 为预防性支架专门行胰管导丝置入与自然发生相比,胰腺炎风险无明确关联(OR 0.82,95%CI 0.37-1.84)。
- 置入支架耗费大量努力与非大量努力相比,胰腺炎风险无明确关联(OR 1.58,95%CI 0.73-3.45)。
- 支架长度大于5 cm与小于等于5 cm相比,胰腺炎风险无明确关联(OR 1.01,95%CI 0.63-1.61)。
- 支架直径大于等于5 Fr与小于5 Fr相比,胰腺炎风险无明确关联(OR 1.13,95%CI 0.65-1.96)。
关键数值与推荐
- 为预防性支架专门行胰管导丝置入对比自然发生:OR 0.82,95%CI 0.37-1.84。
- 置入支架耗费大量努力对比非大量努力:OR 1.58,95%CI 0.73-3.45。
- 支架长度大于5 cm对比小于等于5 cm:OR 1.01,95%CI 0.63-1.61。
- 支架直径大于等于5 Fr对比小于5 Fr:OR 1.13,95%CI 0.65-1.96。
- 导丝口径0.035英寸对比0.025英寸:OR 0.83,95%CI 0.49-1.41。
临床怎么用
- 原文未据此给出推荐;作者认为这些发现可能对操作决策有重要意义,并提示预防性胰腺支架的获益对技术操作差异稳健。
局限性
- 原文明确本研究为事后亚组分析(post hoc subgroup analysis),结论须在该局限内解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Prophylactic pancreatic stent placement (PSP) is effective for preventing pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) in high-risk cases, but the optimal technical approach to this intervention remains uncertain. METHODS: In this secondary analysis of 787 clinical trial patients who underwent successful stent placement, we studied the impact of (i) whether pancreatic wire access was achieved for the sole purpose of PSP or naturally during the conduct of the case, (ii) the amount of effort expended on PSP, (iii) stent length, (iv) stent diameter, and (v) guidewire caliber. We used logistic regression models to examine the adjusted association between each technical factor and post-ERCP pancreatitis (PEP). RESULTS: Ninety-one of the 787 patients experienced PEP. There was no clear association between PEP and whether pancreatic wire access was achieved for the sole purpose of PSP (vs occurring naturally; odds ratio [OR] 0.82, 95% confidence interval [CI] 0.37-1.84), whether substantial effort expended on stent placement (vs nonsubstantial effort; OR 1.58, 95% CI 0.73-3.45), stent length (>5 vs ≤5 cm; OR 1.01, 95% CI 0.63-1.61), stent diameter (≥5 vs <5 Fr; OR 1.13, 95% CI 0.65-1.96), or guidewire caliber (0.035 vs 0.025 in; 0.83, 95% CI 0.49-1.41). DISCUSSION: The 5 modifiable technical factors studied in this secondary analysis of large-scale randomized trial data did not appear to have a strong impact on the benefit of prophylactic PSP in preventing PEP after high-risk ERCP. Within the limitations of post hoc subgroup analysis, these findings may have important implications in procedural decision making and suggest that the benefit of PSP is robust to variations in technical approach.
引用
- Elmunzer BJ, Zhang J, Coté GA, et al. Technical Factors Associated With the Benefit of Prophylactic Pancreatic Stent Placement During High-Risk Endoscopic Retrograde Cholangiopancreatography: A Secondary Analysis of the SVI Trial Data Set. Am J Gastroenterol. 2024. PMID: 39207308. doi:10.14309/ajg.0000000000003052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。